Pharmaceutical innovation saves lives. But not every “new” drug is truly new.
Patents are designed to reward breakthrough inventions by granting the inventors temporary monopoly rights to recoup the costs of research and development and to encourage future innovation[1]. But firms may also exploit the system[2] in ways that make drugs more expensive and less accessible to patients. A 2023 study found that 78% of drugs[3]...